LOQUS23 THERAPEUTICS LIMITED
Research and experimental development on biotechnology
LOQUS23 THERAPEUTICS LIMITED
Research and experimental development on biotechnology
Contact & Details
Contact
Full company profile for LOQUS23 THERAPEUTICS LIMITED (11914774), an active life sciences and medical technology company based in United Kingdom. Incorporated 29 Mar 2019. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2019–2024)
Cash in Bank
£12.48M
Net Assets
£16.81M
Total Liabilities
£790.67k
Turnover
N/A
Employees
7
Debt Ratio
4%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2023 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (4)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 4 | Jan 2019 | Seed |
| Investor 3 | Nov 2021 | Series A, Seed |
| Investor 1 | Oct 2024 | Series A |
See all 4 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Jung, Christian Billy, Dr | Director | Luxembourger | Germany | 3 Mar 2020 | Active |
| Rooswinkel, Rogier Wouter, Dr | Director | Dutch | Netherlands | 6 Sept 2024 | Active |
See all 9 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (2)
Ddf Parallel Llp
United Kingdom
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Dementia Discovery Gp Lp.
United Kingdom
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Novartis Ag
Ceased 6 Sept 2024
Sv Health Managers Llp
Ceased 29 Mar 2019
Group Structure
Group Structure
Charges
Charges
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 2 Apr 2026 | Confirmation Statement | Confirmation statement made on 2026-03-28 with updates | |
| 19 Mar 2026 | Capital | Capital Name Of Class Of Shares | |
| 19 Mar 2026 | Capital | Capital Return Purchase Own Shares | |
| 19 Mar 2026 | Capital | Capital Cancellation Shares | |
| 18 Feb 2026 | Officers | Termination of Melanie Jane Ivarsson as director on 2026-01-22 |
Confirmation statement made on 2026-03-28 with updates
Capital Name Of Class Of Shares
Capital Return Purchase Own Shares
Capital Cancellation Shares
Termination of Melanie Jane Ivarsson as director on 2026-01-22
Recent Activity
Latest Activity
Confirmation statement made on 2026-03-28 with updates
2 weeks ago on 2 Apr 2026
Capital Name Of Class Of Shares
1 months ago on 19 Mar 2026
Capital Return Purchase Own Shares
1 months ago on 19 Mar 2026
Capital Cancellation Shares
1 months ago on 19 Mar 2026
Termination of Melanie Jane Ivarsson as director on 2026-01-22
1 months ago on 18 Feb 2026